RIvaroxaban and VAscular Surgery (RIVAS): insights from a multicenter, worldwide web-based survey
- PMID: 38298049
- DOI: 10.23736/S0392-9590.24.05146-0
RIvaroxaban and VAscular Surgery (RIVAS): insights from a multicenter, worldwide web-based survey
Similar articles
-
Rivaroxaban: from ROCKET-AF trial to routine practice in Spain.Future Cardiol. 2018 May;14(3s):1-2. doi: 10.2217/fca-2018-0019. Future Cardiol. 2018. PMID: 29848088 No abstract available.
-
VOYAGER PAD contributes to medical therapy for peripheral artery disease.J Vasc Surg. 2020 Dec;72(6):1843-1844. doi: 10.1016/j.jvs.2020.06.101. J Vasc Surg. 2020. PMID: 33222822 No abstract available.
-
Rivaroxaban for the treatment of superficial vein thrombosis, experience at King's College Hospital.Br J Haematol. 2022 Jan;196(1):e3-e6. doi: 10.1111/bjh.17757. Epub 2021 Aug 5. Br J Haematol. 2022. PMID: 34355385 No abstract available.
-
The Rivaroxaban Program and the Management of Unmet Needs in Thromboembolic Disease.Thromb Haemost. 2018 May;118(S 01):S2-S11. doi: 10.1055/s-0038-1632387. Epub 2018 Mar 22. Thromb Haemost. 2018. PMID: 29566415 Review.
-
Rivaroxaban: A New Treatment Paradigm in the Setting of Vascular Protection?Thromb Haemost. 2018 May;118(S 01):S12-S22. doi: 10.1055/s-0038-1636530. Epub 2018 Mar 22. Thromb Haemost. 2018. PMID: 29566413 Review.
Cited by
-
Safety and effectiveness of single ProStyle™/ProGlide™ for aortic endovascular procedures: single-style study.Front Cardiovasc Med. 2025 Jul 3;12:1559131. doi: 10.3389/fcvm.2025.1559131. eCollection 2025. Front Cardiovasc Med. 2025. PMID: 40678573 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources